Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-11-10 5:49 pm Purchase | 2026-09-30 | 13G | SUNSHINE BIOPHARMA INC PAR SBFM | Mitchell P. Kopin | 430,336 9.990% | 418,551 (+3551.56%) | Filing History |
| 2026-10-14 10:41 am Purchase | 2026-10-08 | 13G | SUNSHINE BIOPHARMA INC PAR SBFM | BJI Financial Group | 45,495 6.000% | 45,495 (New Position) | Filing History |
| 2026-10-13 4:20 pm Purchase | 2026-10-08 | 13G | SUNSHINE BIOPHARMA INC PAR SBFM | CVI Investments, Inc. | 79,413 9.900% | 79,413 (New Position) | Filing History |
| 2026-10-05 4:06 pm Unchanged | 2026-08-13 | 13G | SUNSHINE BIOPHARMA INC PAR SBFM | Alta Partners LLC | 10,000 4.900% | 0 (Unchanged) | Filing History |
| 2026-08-14 4:10 pm Purchase | 2026-08-14 | 13G | SUNSHINE BIOPHARMA INC PAR SBFM | L1 Capital Global Opportunities Master Fund, Ltd. | 5,577 4.990% | 577 (+11.54%) | Filing History |
| 2026-08-13 10:21 am Purchase | 2026-06-30 | 13G | SUNSHINE BIOPHARMA INC PAR SBFM | Mitchell P. Kopin | 11,785 9.990% | 9,257 (+366.18%) | Filing History |
| 2026-07-08 6:05 pm Purchase | 2026-07-08 | 13G | SUNSHINE BIOPHARMA INC PAR SBFM | Alta Partners LLC | 10,000 8.600% | 10,000 (New Position) | Filing History |
| 2026-05-22 4:10 pm Purchase | 2026-05-18 | 13G | SUNSHINE BIOPHARMA INC PAR SBFM | L1 Capital Global Opportunities Master Fund, Ltd. | 5,000 5.830% | 4,289 (+603.23%) | Filing History |
| 2026-05-21 4:16 pm Purchase | 2026-05-18 | 13G | SUNSHINE BIOPHARMA INC PAR SBFM | BIGGER CAPITAL FUND L P | 8,050 9.470% | 8,050 (New Position) | Filing History |
| 2025-08-14 10:35 am Sale | 2025-06-30 | 13G | SUNSHINE BIOPHARMA INC PAR SBFM | Altium Capital Management LLC | 0 0.000% | -23 (Position Closed) | Filing History |
| 2025-06-12 8:24 pm Sale | 2025-06-10 | 13G | SUNSHINE BIOPHARMA INC PAR SBFM | BIGGER CAPITAL FUND L P | 0 0.000% | -1,486 (Position Closed) | Filing History |
| 2025-05-23 4:17 pm Purchase | 2025-05-19 | 13G | SUNSHINE BIOPHARMA INC PAR SBFM | Mitchell P. Kopin | 2,528 9.990% | 2,528 (New Position) | Filing History |
| 2025-04-11 5:02 pm Purchase | 2025-04-02 | 13G | SUNSHINE BIOPHARMA INC PAR SBFM | BIGGER CAPITAL FUND L P | 1,486 8.170% | 1,486 (New Position) | Filing History |
| 2025-02-14 4:43 pm Purchase | 2024-12-31 | 13G | SUNSHINE BIOPHARMA INC SBFM | L1 Capital Global Opportunities Master Fund, Ltd. | 711 4.990% | 698 (+5369.23%) | Filing History |
| 2024-11-14 4:28 pm Sale | 2024-09-30 | 13G | SUNSHINE BIOPHARMA INC PAR SBFM | Armistice Capital, LLC | 0 0.000% | -5 (Position Closed) | Filing History |
| 2024-02-23 4:03 pm Purchase | 2024-02-13 | 13G | SUNSHINE BIOPHARMA INC SBFM | L1 Capital Global Opportunities Master Fund, Ltd. | 13 5.300% | 13 (New Position) | Filing History |
| 2024-02-21 4:28 pm Purchase | 2024-02-13 | 13G | SUNSHINE BIOPHARMA INC SBFM | Altium Capital Management LLC | 23 9.990% | 23 (New Position) | Filing History |
| 2024-02-14 3:53 pm Purchase | 2023-12-31 | 13G | SUNSHINE BIOPHARMA INC SBFM | Armistice Capital, LLC | 5 7.600% | 5 (New Position) | Filing History |
| 2022-11-02 11:13 am Purchase | 2022-10-20 | 13G | SUNSHINE BIOPHARMA INC SBFM | Chamoun Malek | 9 16.400% | 9 (New Position) | Filing History |